Phase Focus Limited

Phase Focus Limited specializes in advanced imaging technologies, focusing on live cell analysis through its proprietary Livecyte system, which employs quantitative phase imaging for research in various biological fields. Phase Focus Limited is focused on the development of innovative imaging solutions. The company is headquartered in Sheffield, UK. The CEO is Martin Humphry.

The company has successfully completed 15 investment deals. Its latest funding round raised GBP 0. 150 mn through Braveheart Investment Group, bringing the total amount raised to GBP 0. 150 mn and valuing the company at GBP 2.

400 mn. Fusion IP, White Rose Technology Seedcorn Fund, YFM Equity Partners, Yorkshire Forward Regional Development Agency, Credit Protection Association, UK Technology Strategy Board, and Ombu Group have exited their stake in Phase Focus for an undisclosed amount. Phase Focus Limited specializes in the development of advanced imaging technologies, primarily through its flagship product, Livecyte. This innovative system employs patented label-free quantitative phase imaging (QPI) technology, specifically utilizing a technique known as Ptychography, to facilitate automated tracking and analysis of live cell populations.

Livecyte enables researchers to assess various cellular characteristics, including growth, morphology, and motility, in a 96-well plate assay format. The technology serves critical needs in fields such as oncology, immunology, and stem cell research, and is utilized by academic institutions and research organizations across North America, Europe, and Asia-Pacific. Phase Focus Limited generates revenue primarily through the sale of its Livecyte imaging systems and associated services, which are structured around B2B transactions. The revenue for the most recent year was GBP 305,198.

40, while the EBITDA for the same year was GBP -1,411,994. 50. Clients, including research institutions and biotechnology companies, typically engage in purchasing agreements for the systems, along with ongoing support services and accessories, such as the Cell Analysis Toolbox. Phase Focus Limited plans to expand its product lineup by developing new features for the Livecyte system and aims to introduce these enhancements by the end of the forthcoming year.

Additionally, the company is targeting expansion into new markets in North America and Asia-Pacific, with specific plans to establish a presence in these regions within the next two years. Recent funding will support these initiatives, allowing the company to enhance its research and development capabilities and expand marketing efforts to establish a stronger foothold in these high-potential markets.